An automated communication system in a contact registry for persons with rare diseases: Scalable tools for identifying and recruiting clinical research participants

Contemporary Clinical Trials

Volumn 30, Issue 1, 2009, Pages 55-62

  Richesson, R L ^a   Lee, H S ^a   Cuthbertson, D ^a   Lloyd, J ^a   Young, K ^a   Krischer, J P ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Patient selection; Rare diseases; Registries

Indexed keywords

ARTICLE; ARTIFICIAL NEURAL NETWORK; AUTOMATION; CLINICAL RESEARCH; COMPARATIVE STUDY; E-MAIL; INTERNET; INTERPERSONAL COMMUNICATION; MASS COMMUNICATION; PATIENT PARTICIPATION; PATIENT SELECTION; RARE DISEASE; REGISTER;

CLINICAL TRIALS AS TOPIC; ELECTRONIC MAIL; HUMANS; INFORMED CONSENT; INTERNET; PATIENT SELECTION; RARE DISEASES; REGISTRIES; RESEARCH DESIGN; RESEARCH SUBJECTS;

EID: 57649105507     PISSN: 15517144     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cct.2008.09.002     Document Type: Article

References (57)

1. Hampton T. Rare disease research gets boost. JAMA 295 (2006) 2836-2838
2. Aitken L., Gallagher R., and Madronio C. Principles of recruitment and retention in clinical trials. Int J Nurs Pract 9 6 (2003) 338-346
3. Rare Diseases Act of 2002. [Page 116 STAT. 1988] Public Law 107-280. 107th Congress, http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=107_cong_publi c_laws&docid=f:publ280.107.
4. PEC. Rare Disease Clinical Research Network Public Website, Pediatrics Epidemiology Center (2006). http://www.rarediseasesnetwork.org http://www.rarediseasesnetwork.org
5. Parkin D.M. The evolution of the population-based cancer registry. Nat Rev 6 (2006) 603-612
6. Pastores G.M. The MPS I registry: design, methodology, and early findings of a global disease registry for monitoring patients with Mucopolysaccharidosis Type I. Mol Genet Metab 91 1 (2007) 37-47
7. Montano A.M., et al. International Morquio A Registry: clinical manifestation and natural course of Morquio A disease. J Inherit Metab Dis 30 2 (2007) 165-174
8. Eng C.M., et al. Fabry disease: baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry. J Inherit Metab Dis 30 2 (2007) 184-192
9. Tattersfield A.E., and Glassberg M.K. Lymphangioleiomyomatosis: a national registry for a rare disease. Am J Respir Crit Care Med 173 1 (2006) 2-4
10. Hampton T. Parkinson disease registry launched. JAMA 293 2 (2005) 149
11. Berger B., et al. The prevalence of diabetes in a Swedish population of 280,411 inhabitants. A report from the Skaraborg Diabetes Registry. Diabetes Care 21 4 (1998) 546-548
12. Berger B., Stenstrom G., and Sundkvist G. Incidence, prevalence, and mortality of diabetes in a large population. A report from the Skaraborg Diabetes Registry. Diabetes Care 22 5 (1999) 773-778
13. Brown J., Glauber H., and Nichols G. Impact on a population-based registry of changing diagnostic thresholds for diabetes. Diabetes Care 21 8 (1998) 1374-1375
14. Bruno G., et al. Incidence of type 1 and type 2 diabetes in adults aged 30-49 years: the population-based registry in the province of Turin, Italy. Diabetes Care 28 11 (2005) 2613-2619
15. Nielsen G.L., et al. Analyses of data quality in registries concerning diabetes mellitus-a comparison between a population based hospital discharge and an insulin prescription registry. J Med Syst 20 1 (1996) 1-10
16. Palta M., et al. Longitudinal patterns of glycemic control and diabetes care from diagnosis in a population-based cohort with type 1 diabetes. The Wisconsin Diabetes Registry. Am J Epidemiol 144 10 (1996) 954-961
17. Tenconi M.T., et al. The incidence of insulin-dependent diabetes mellitus: preliminary data from an organized population registry in Pavia Province. Epidemiol Prev 13 48-49 (1991) 149-150
18. Fishman N.W., et al. New Approaches to Coronary Intervention (NACI) registry: history and methods. Am J Cardiol 80 10A (1997) 10K-18K
19. Deng M.C., et al. Mechanical circulatory support device database of the International Society for Heart and Lung Transplantation: third annual report-2005. J Heart Lung Transplant 24 (2005) 1182-1187
20. Peelen L., et al. The use of a registry database in clinical trial design: assessing the influence of entry criteria on statistical power and number of eligible patients. Int J Med Inform 76 2-3 (2007) 176-183
21. Bossi A., et al. What is the incidence of cystic fibrosis in Italy? Data from the National Registry (1988-2001). Hum Biol 76 3 (2004) 455-467
22. Viviani L., et al. The Italian registry for cystic fibrosis: what has changed in the last decade. Epidemiol Prev 27 2 (2003) 91-96
23. Lai H.J., Cheng Y., and Farrell P.M. The survival advantage of patients with cystic fibrosis diagnosed through neonatal screening: evidence from the United States Cystic Fibrosis Foundation registry data. J Pediatr 147 3 Suppl (2005) S57-S63
24. Wang S.S., et al. Early diagnosis of cystic fibrosis in the newborn period and risk of Pseudomonas aeruginosa acquisition in the first 10 years of life: a registry-based longitudinal study. Pediatrics 107 2 (2001) 274-279
25. Lai H.C., et al. Growth status in children with cystic fibrosis based on the National Cystic Fibrosis Patient Registry data: evaluation of various criteria used to identify malnutrition. J Pediatr 132 3 Pt 1 (1998) 478-485
26. Koch C., et al. International practice patterns by age and severity of lung disease in cystic fibrosis: data from the Epidemiologic Registry of Cystic Fibrosis (ERCF). Pediatr Pulmonol 24 2 (1997) 147-154 discussion 159-61
27. Koch C., et al. Presence of cystic fibrosis-related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: data from the European Epidemiologic Registry of Cystic Fibrosis. Pediatr Pulmonol 32 5 (2001) 343-350
28. Mastella G., et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. Epidemiologic Registry of Cystic Fibrosis. Eur Respir J 16 3 (2000) 464-471
29. Melzi M.L., et al. Liver transplant in cystic fibrosis: a poll among European centers. A study from the European Liver Transplant Registry. Transpl Int 19 9 (2006) 726-731
30. Koch C., et al. European Epidemiologic Registry of Cystic Fibrosis (ERCF): comparison of major disease manifestations between patients with different classes of mutations. Pediatr Pulmonol 31 1 (2001) 1-12
31. McCormick J., et al. Comparative analysis of Cystic Fibrosis Registry data from the UK with USA, France and Australasia. J Cyst Fibros 4 2 (2005) 115-122
32. Singer R.B. Cystic fibrosis mortality: registry data of cystic fibrosis. J Insur Med 29 4 (1997) 233-239
33. Masson S., et al. Clinical correlates of elevated plasma natriuretic peptides and Big endothelin-1 in a population of ambulatory patients with heart failure. A substudy of the Italian Network on Congestive Heart Failure (IN-CHF) registry. IN-CHF Investigators. Ital Heart J 1 4 (2000) 282-288
34. Bossi A., et al. Italian Cystic Fibrosis Registry: 10 years of activity. Epidemiol Prev 23 1 (1999) 5-16
35. Guilloud-Bataille M., et al. Cystic fibrosis mutations: report from the French Registry. The Clinical Centers of the CF. Hum Hered 50 2 (2000) 142-145
36. Schoni-Affolter F., et al. Swiss registry for patients with cystic fibrosis: design, programming, implementation and first examples of use. Schweiz Med Wochenschr 130 39 (2000) 1373-1381
37. Chang S.M., et al. Clinical trial participation among patients enrolled in the Glioma Outcomes Project. Cancer 94 10 (2002) 2681-2687
38. Andersen M.R., et al. Using a population-based cancer registry for recruitment of newly diagnosed patients with ovarian cancer. Am J Clin Oncol 28 1 (2005) 17-20
39. Martens W., et al. Resources of NIH Registry of Myotonic Dystrophy (DM) and FSHD patients and family members. 5th International Myotonic Dystrophy Consortium (2005), Quebec, Quebec City
40. Moon T.E., et al. Design and recruitment for retinoid skin cancer prevention (SKICAP) trials. The Southwest Skin Cancer Prevention Study Group. Cancer Epidemiol Biomark Prev 4 6 (1995) 661-669
41. Electronic Newsletter. National Registry of Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Patients and Family Members., University of Rochester Medical Center (2007). http://www.urmc.rochester.edu/nihregistry/pubs/pubs.cfm http://www.urmc.rochester.edu/nihregistry/pubs/pubs.cfm
42. Sugarman J., et al. Ethical ramifications of alternative means of recruiting research participants from cancer registries. Cancer 86 4 (1999) 647-651
43. Beskow L.M., Sandler R.S., and Weinberger M. Research recruitment through US central cancer registries: balancing privacy and scientific issues. Am J Public Health 96 11 (2006) 1920-1926
44. Beskow L.M., et al. Patient perspectives on research recruitment through cancer registries. Cancer Causes Control 16 10 (2005) 1171-1175
45. Paul J., Seib R., and Prescott T. The Internet and clinical trials: background, online resources, examples and issues. J Med Internet Res 7 1 (2005) e5
46. Marks R., B.H., Conlon M., and Pepine C.J. Enhancing clinical trials on the internet: lessons from INVEST. Clin Cardiol 24 11 Suppl (2001) V17-V23
47. Zarin D.A., et al. Issues in the registration of clinical trials. JAMA 297 19 (2007) 2112-2120
48. Hirsch L.J. Clinical trial registry initiative. Bull World Health Organ 84 4 (2006) 336
49. Sipkoff, M., Support grows for establishing national clinical trial registry. Manag Care, 2005. 14(7): 24, 26.
50. Van Der Weyden M.B., and Ghersi D. The Australian Clinical Trial Registry. Med J Aust 183 1 (2005) 7
51. Scroccaro G., et al. Registering clinical trials. Italian clinical trial registry is kept by pharmacists on local ethical committees. BMJ 320 7245 (2000) 1340
52. Zarin D.A., and Keselman A. Registering a clinical trial in ClinicalTrials.gov. Chest 131 3 (2007) 909-912
53. Friebel T.M., et al. Active recruitment increased enrollment in a hereditary cancer registry. J Clin Epidemiol 57 11 (2004) 1172-1176
54. Phipps E., et al. Investigation of ethnic differences in willingness to enroll in a rehabilitation research registry: a study of the Northeast Cognitive Rehabilitation Research Network. Am J Phys Med Rehabil 83 12 (2004) 875-883
55. Ellington L., et al. Decision-making issues for randomized clinical trial participation among Hispanics. Cancer Control 10 5 Suppl (2003) 84-86
56. Brown R.F., et al. Promoting patient participation and shortening cancer consultations: a randomised trial. Br J Cancer 85 9 (2001) 1273-1279
57. Jeffe D.B., et al. Frail older women's participation in a trial of hormone replacement therapy: perceived benefits and concerns. Menopause 8 2 (2001) 127-134